Infliximab for Crohn's disease perianal fistulae discussed

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.366, 2002-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab/infliximab: Mucinous adenocarcinoma in patients with perianal Crohn's disease: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1366, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Imaging Modalities for Perianal Crohn's Disease

By  

Current Drug Targets, Vol. 13, Iss. 10, 2012-09 ,pp. : 1287-1293

Bentham Science Publishers

Access to resources Recommend Favorite

Infliximab promising in paediatric Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Infliximab: additional benefits in Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Infliximab worth it for Crohn's disease in the UK

By  

Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite